Vivoryon Therapeutics NV
F:05Y
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vivoryon Therapeutics NV
F:05Y
|
DE |
|
Warner Bros Discovery Inc
NASDAQ:WBD
|
US |
|
W
|
WP Carey Inc
F:WPY
|
US |
|
G
|
Grindrod Ltd
JSE:GND
|
ZA |
|
BAE Systems PLC
LSE:BA
|
UK |
|
National Bank of Canada
TSX:NA
|
CA |
|
C
|
Ceconomy AG
DUS:CEC
|
DE |
|
ASM International NV
OTC:ASMXF
|
NL |
|
R
|
Rheinmetall AG
XHAM:RHM
|
DE |
|
MTR Corp Ltd
HKEX:66
|
HK |
|
Ooma Inc
NYSE:OOMA
|
US |
Wall St Price Targets
05Y Price Targets Summary
Vivoryon Therapeutics NV
According to Wall Street analysts, the average 1-year price target for
05Y is 5.73 EUR with a low forecast of 5.05 EUR and a high forecast of 7.19 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 05Y's stock price target?
Price Target
5.73
EUR
According to Wall Street analysts, the average 1-year price target for
05Y is 5.73 EUR with a low forecast of 5.05 EUR and a high forecast of 7.19 EUR.